From innate to adaptive immune responses in contact hypersensitivity

Current Opinion in Allergy and Clinical Immunology

Volumn 8, Issue 4, 2008, Pages 289-293

  Martin, Stefan F ^a   Jakob, Thilo ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti inflammatory therapy; Contact allergen; Inflammasome; Inflammation; Toll like receptor

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CHEMICAL AGENT; CONTACT ALLERGEN; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEPACRINE; METAL ION; N ACETYLGLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PATTERN RECOGNITION RECEPTOR; ENDOCANNABINOID; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIINFLAMMATORY ACTIVITY; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTACT DERMATITIS; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MOLECULAR MECHANICS; NONHUMAN; PLANT; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; ANIMAL; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LANGERHANS CELL; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DERMATITIS, CONTACT; ENDOCANNABINOIDS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOTHERAPY; LANGERHANS CELLS; MICE; TOLL-LIKE RECEPTORS;

EID: 53049105392     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283088cf9     Document Type: Review

References (33)

1. Martin SF. In: Pichler WJ, editor. Drug hypersensitivity. Basel: Karger; 2007. pp. 34-46.
2. Edele F, Esser PN, Lass C, et al. Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm Allergy Drug Targets 2007; 6:236-244.
3. van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 2007; 7:374-381.
4. Grabbe S, Steinert M, Mahnke K, et al. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J Clin Invest 1996; 98:1158-1164.
5. Bonneville M, Chavagnac C, Vocanson M, et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007; 127:1430-1435.
6. Seidel-Guyenot W, Perschon S, Dechant N, et al. Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. J Allergy Clin Immunol 2006; 117:1170-1177.
7. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006; 27:352-357.
8. Antonopoulos C, Cumberbatch M, Mee JB, et al. IL-1 8 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 2008; 83:361 -367.
9. Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622.
10. Watanabe H, Gaide O, Petrilli V, et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007; 127:1956-1963.
11. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-241.
12. Mariathasan S, Weiss DS, Newton K, McBride J, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228-232.
13. Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for NALP3/CIAS1 / Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006; 24:317-327.
14. Di NardoA, Braff MH, Taylor KR, et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol 2007; 178:1829-1834.
15. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7:507-516.
16. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al.. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8:1095-1104.
17. Bennett CL, Clausen BE. DC ablation in mice: promises, pitfalls, and chal-lenges. Trends Immunol 2007; 28:525-531.
18. Fukunaga A, Khaskhely NM, Sreevidya CS, et al. Dermal dendritic cells, and not langerhans cells, play an essential role in inducing an immune response. J Immunol 2008; 180:3057-3064.
19. Bennett CL, Noordegraaf M, Martina CA, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007; 179:6830-6835.
20. Bennett CL, van Rijn E, Jung S, et al.. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169:569-576.
21. Bursch LS, Wang L, Igyarto B, et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204:3147-3156.
22. Oka S, Wakui J, Ikeda S, et al.. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 2006; 177:8796-8805.
23. Karsak M, Gaffal E, Date R, et al. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 2007; 316:1494-1497.
24. Tuckermann JP, Kleiman A, Moriggl R, et al.. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 2007; 117:1381 -1390.
25. Luger TA, Brzoska T. alpha-MSH related peptides: a new class of anti-inflam-matory and immunomodulating drugs. Ann Rheum Dis 2007; 66 (Suppl 3): iii52-iii55.
26. Gordon JS, Wolanin PM, Gonzalez AV, et al. Topical N-acetyl-S-farnesyl-L-cysteine inhibits mouse skin inflammation, and unlike dexamethasone, its effects are restricted to the application site. J Invest Dermatol 2007; 128:643-654.
27. Gorbachev AV, Gasparian AV, Gurova KV, et al. Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol 2007; 37:2257-2267.
28. Gainers ME, Descheny L, Barthel SR, et al.. Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis. J Immunol 2007; 179:8509-8518.
29. Oostingh GJ, Ludwig RJ, Enders S, et al. Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J Invest Dermatol 2007; 127:90-97.
30. Park KB, Dalton-Brown E, Hirst C, Williams DP. Selection of new chemical entities with decreased potential for adverse drug reactions. Eur J Pharmacol 2006; 549:1 -8.
31. Dinkova-KostovaAT, Holtzclaw WD, KenslerTW. The role of Keap1 in cellular protective responses. Chem Res Toxicol 2005; 18:1779-1791.
32. Natsch A, Emter R. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol Sci 2008; 102:110-119.
33. Kim HJ, Barajas B, Wang M, Nel AE. Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells. J Allergy Clin Immunol 2008; 121:1255-1261.